Equities analysts expect Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Rating) to announce earnings of ($0.26) per share for the current quarter, according to Zacks. Three analysts have made estimates for Amicus Therapeutics’ earnings, with the highest EPS estimate coming in at ($0.17) and the lowest estimate coming in at ($0.30). Amicus Therapeutics posted earnings of […]
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 867 13F filings that hedge funds and well-known value investors are required to file by the SEC.
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database.